Nano-enabled nasal spray for osteoporosis
Monday, February 20, 2012 - 08:03
in Health & Medicine
The University of Nottingham spin-out company, Critical Pharmaceuticals, has announced a £545,000 collaboration with the University to develop a nano-enabled intranasal formulation of teriparatide for the treatment of osteoporosis.